Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Diabetes & Metabolic Syndrome|June 25, 2016
The association between educational resource utilization and knowledge/self-management among patients with Type 2 Diabetes in Pune, IndiaKarina Javalkar, Nicole Williamson, Saleena Vaidya, et al.
Respiratory Physiology & Neurobiology|November 12, 2013
Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot studyRavikumar Sinojia, Moin Shaikh, Rahul Kodgule, et al.
Pulmonary Pharmacology & Therapeutics|September 12, 2017
Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trialAkash Balki, S Balamurugan, Suhas Bardapurkar, et al.
BMC Pulmonary Medicine|May 10, 2024
Comparison of a portable, pneumotach flow-sensor-based spirometer (Spirofy™) with the vitalograph alpha Touch™ spirometer in evaluating lung function in healthy individuals, asthmatics, and COPD patients-a randomized, crossover studyDeepak Talwar, S Balamurugan, Mahavir Modi, et al.
The AAPS Journal|May 24, 2015
Regulatory Considerations for Approval of Generic Inhalation Drug Products in the US, EU, Brazil, China, and IndiaSau L Lee, Bhawana Saluja, Alfredo García-Arieta, et al.
Drugs - Real World Outcomes|October 28, 2025
Outcomes and Usability of Formoterol-Budesonide Delivered Through Synchrobreathe® in Patients With Chronic Obstructive Pulmonary Disease: The EMERGE StudySanthalingam Balamurugan, Himanshu Pophale, Utsav Samariya, et al.
Pulmonary Pharmacology & Therapeutics|December 4, 2019
Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in IndiaAloke Ghoshal, Pradyut Waghray, George Dsouza, et al.
Respiratory Medicine|February 15, 2020
Device-handling study of a novel breath-actuated inhaler, Synchrobreathe®, versus a pMDISanthalingam Balamurugan, Komalkirti Apte, Bhanu Pratap Singh, et al.
Lung India : Official Organ of Indian Chest Society|January 11, 2023
Efficacy and safety of glycopyrronium/formoterol delivered via a dry powder inhaler in patients with moderate to severe chronic obstructive pulmonary disease: Results from a multi-centre, open-label, randomised studySundeep Salvi, Anand Kumar, Sumit Agrawal, et al.
Pulmonary Pharmacology & Therapeutics|August 11, 2020
Fixed-dose combination of three drugs, i.e. LABA/LAMA/ICS for COPD: Results of a real-world study from IndiaSundeep Salvi, Ashish Kumar Deb, Mayank Agarwal, et al.
Pageof 2